Financial

The company says its product is best used for follow-up appointments, test results, medication refills, after hours care and doctor-to-doctor communication.

The funding will go towards further development of the "Health Storylines" platform that allows providers and health plans to engage and learn from patients.

The company plans to use the new funds to keep working on its DNA-printing technology, and to start development of its own incubator.

Sensiotec was selected as CHT's first direct investment based on the VMA's potential to improve clinical outcomes and reduce costs across the care continuum.

The not-for-profit organization is scheduled to open in early 2015 and is currently accepting applications for membership, which starts at $150 per month.

Proceeds from the financing will enable InfoBionic to commercialize its MoMe System, a remote patient monitoring platform for cardiac arrhythmia detection.

The new money will be used for the organization to serve even more provider organizations more quickly; Nashville-based VC Heritage Group led the round.

The company makes the technology that enables users to connect to their wellness at the molecular level, allowing for a deeper level of health tracking.

The company makes experimental process design and analytics software to improve reproducibility and tech transfer in life science, chemical and materials R&D.

The company offers a hyper-realistic video communication system that is set up inside a regular physician office to allow for doctor-patient communication.